デフォルト表紙
市場調査レポート
商品コード
1465922

TCR療法の世界市場レポート 2024年

TCR Therapy Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
TCR療法の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

TCR療法の市場規模は、今後数年で飛躍的な成長が見込まれます。2028年には年間平均成長率(CAGR)37.0%で6億5,000万米ドルに成長します。予測期間中に予想される成長は、進行中の臨床試験の急増、ヘルスケアにおける革新的技術の採用、固形がんへの幅広い応用、規制当局の後押し、承認プロセスの合理化、補完療法との統合など、さまざまな要因に起因するとみられます。この期間に予測される世界の動向には、固形がんへの拡大、次世代TCR工学の進歩、個別化および新抗原同定の増加、国際共同研究、戦略的パートナーシップ、免疫学および腫瘍生物学における進行中の研究などが含まれます。

がんの有病率の上昇は、当面のTCR療法市場の拡大を牽引すると予想されます。がんは、体内での異常細胞の抑制されない増殖と拡散を特徴とする病態であり、健康な組織に浸潤して損傷し、臓器機能と全身の健康を損なう可能性があるため、重大な脅威となっています。この現象は、ライフスタイルの選択、高齢化、肥満の蔓延、遺伝的素因などに起因しています。T細胞受容体(TCR)療法は、がん治療を選択的に標的とし、その効果を高める免疫系の能力を利用するもので、この病気に対処する画期的なアプローチとなりうる。例えば、英国のヘルスケア慈善団体であるマクミラン・キャンサー・サポートは、2022年10月に、がん患者数が2020年の300万人から2025年には350万人、2030年には400万人、2040年には530万人に増加すると予測し、TCR療法市場の成長の原動力を強調しています。

TCR療法分野の大手企業は、患者に必要不可欠な治療法を提供し、競争上の優位性を獲得するために、戦略的パートナーシップ戦略を採用しています。戦略的パートナーシップとは、互いの強みとリソースを活用し、相互利益と成功を目指すものです。例えば、2023年12月、米国を拠点とするバイオテクノロジー企業ImmunoScape社は、シンガポールの製薬会社Experimental Drug Development Centre(EDDC)と、固形がんを標的とする新規TCRベースの二重特異性分子の開発で提携しました。この共同研究は、ImmunoScape社のシステム免疫学と計算生物学の専門知識とEDDC社の能力を活用し、研究を推進し、それぞれの強みを生かした戦略的提携を確立することで、より利用しやすく、より効能のある可能性のあるがん治療法の開発を促進することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界のTCR療法市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のTCR療法市場の実績:規模と成長, 2018-2023
  • 世界のTCR療法市場の予測:規模と成長, 2023-2028, 2033F

第6章 市場セグメンテーション

  • 世界のTCR療法市場:製品タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 点滴
  • 注射剤
  • その他の製品タイプ
  • 世界のTCR療法市場:適応症別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 白血病
  • リンパ腫
  • 骨髄腫
  • その他の適応症
  • 世界のTCR療法市場:流通チャネル別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • オンライン
  • オフライン
  • 世界のTCR療法市場:エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 病院薬局
  • 小売薬局
  • 専門クリニック

第7章 地域別・国別分析

  • 世界のTCR療法市場:地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界のTCR療法市場:国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • TCR療法市場:競合情勢
  • TCR療法市場:企業プロファイル
    • Pfizer Inc.
    • Johnson & Johnson Services Inc.
    • Novartis AG
    • Bristol Myers Squibb Company
    • GlaxoSmithKline PLC

第31章 その他の大手企業と革新的企業

  • Gilead Sciences Inc.
  • Bluebird bio Inc.
  • Immunocore Limited
  • Immatics N.V.
  • Poseida Therapeutics Inc.
  • Fate Therapeutics Inc.
  • Atara Biotherapeutics Inc.
  • Intellia Therapeutics Inc.
  • Precision Biosciences Inc.
  • Takara Bio Inc.
  • Tessa Therapeutics
  • Adaptimmune Therapeutics plc
  • Cellectis S.A.
  • Zelluna Immunotherapy AS
  • Cellular Biomedicine Group Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r17241

T-cell receptor (TCR) therapy is a type of immunotherapy that involves modifying a patient's T cells to enhance their ability to detect and combat cancer cells. Primarily utilized in cancer treatment, this therapy aims to leverage the body's immune system to target and eliminate cancerous cells.

TCR therapy encompasses various forms such as infusions, injectables, and other modalities. Infusions typically involve immersing a substance (e.g., herbs, tea leaves, or flavorings) in a liquid (usually hot water) to extract its properties or flavor. This therapy is utilized across multiple conditions including leukemia, lymphoma, myeloma, among others, and is accessible through both online and offline channels. Its end-users span hospital pharmacies, retail pharmacies, and specialty clinics.

The TCR therapy market research report is one of a series of new reports from The Business Research Company that provides TCR therapy market statistics, including TCR therapy industry global market size, regional shares, competitors with a TCR therapy market share, detailed TCR therapy market segments, market trends and opportunities, and any further data you may need to thrive in the TCR therapy industry. This TCR therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The TCR therapy market size has grown exponentially in recent years. It will grow from $0.13 billion in 2023 to $0.18 billion in 2024 at a compound annual growth rate (CAGR) of 40.6%. The growth observed during the historical period can be attributed to several factors, including a rise in cancer incidence, heightened interest in immunotherapy, promising outcomes from clinical trials, and substantial financial backing from investors.

The TCR therapy market size is expected to see exponential growth in the next few years. It will grow to $0.65 billion in 2028 at a compound annual growth rate (CAGR) of 37.0%. The anticipated growth in the forecast period is expected to stem from various factors, including a surge in ongoing clinical trials, the adoption of innovative technologies in healthcare, broader applications in solid tumors, regulatory backing, streamlined approval processes, and integration with complementary therapies. Significant trends projected for this period encompass the expansion into solid tumors, advancements in next-generation TCR engineering, a rise in personalization and neoantigen identification, global collaborations, strategic partnerships, and ongoing research in immunology and tumor biology.

The rising prevalence of cancer is anticipated to drive the expansion of the TCR therapy market in the foreseeable future. Cancer, a condition characterized by the unchecked proliferation and dissemination of abnormal cells in the body, poses a significant threat as it can infiltrate and damage healthy tissues, compromising organ function and systemic health. This phenomenon is attributed to lifestyle choices, the aging demographic, the widespread issue of obesity, and genetic predispositions. T-cell receptor (TCR) therapy exploits the immune system's capabilities to selectively target and enhance the efficacy of cancer treatment, offering a potentially revolutionary approach to addressing the disease. For example, Macmillan Cancer Support, a healthcare charity based in the UK, projected in October 2022 that the number of cancer cases would increase from 3 million in 2020 to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040, underscoring the driving force behind the growth of the TCR therapy market.

Leading players in the TCR therapy sector are embracing a strategic partnership strategy to deliver essential therapies to patients and gain a competitive advantage. Strategic partnerships involve leveraging each other's strengths and resources to achieve mutual benefits and success. For instance, in December 2023, ImmunoScape, a biotechnology company based in the US, collaborated with the Experimental Drug Development Centre (EDDC), a pharmaceutical company in Singapore, to develop novel TCR-based bispecific molecules targeting solid tumors. This collaboration aims to capitalize on ImmunoScape's expertise in systems immunology and computational biology, combined with EDDC's capabilities, to drive research forward and establish a strategic alliance that capitalizes on their respective strengths to expedite the development of more accessible and potentially more efficacious cancer treatments.

In January 2023, AstraZeneca, a pharmaceutical and biotechnology company headquartered in the UK, acquired Neogene Therapeutics Inc. for $320 million, significantly bolstering its presence in the burgeoning field of TCR-T therapy. This acquisition granted AstraZeneca access to cutting-edge technology, valuable expertise, and a shared commitment to advancing new cancer treatments, ultimately aiming to enhance the quality of life for patients across various cancer types. Neogene Therapeutics Inc., a US-based biotechnology company, is dedicated to developing next-generation, fully personalized engineered T-cell therapies for a wide range of cancers.

Major companies operating in the tcr therapy market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline PLC, Gilead Sciences Inc., Bluebird bio Inc., Immunocore Limited, Immatics N.V., Poseida Therapeutics Inc., Fate Therapeutics Inc., Atara Biotherapeutics Inc., Intellia Therapeutics Inc., Precision Biosciences Inc., Takara Bio Inc., Tessa Therapeutics, Adaptimmune Therapeutics plc, Cellectis S.A., Zelluna Immunotherapy AS, Cellular Biomedicine Group Inc., Lion TCR Pte Ltd, TCRCure Biopharma Corp., Asher Biotherapeutics Inc., Be Biopharma Inc., Alaunos Therapeutics Inc., China Immunotech Inc.

North America was the largest region in the TCR therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tcr therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tcr therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The TCR therapy market consists of revenues earned by entities by providing services such as genetic engineering services, quality control and assurance, clinical trial support, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The TCR therapy market also includes sales of TCR constructs, genetic modification tools, viral vectors, delivery systems, cell culture media and reagents, patient monitoring tools, and bioinformatics and data analysis tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

TCR Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on TCR therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for TCR therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The TCR therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product Type: Infusions; Injectables; Other Product Types
  • 2) By Indication: Leukemia; Lymphoma; Myeloma; Other Indication
  • 3) By Distribution Channel: Online; Offline
  • 4) By End-User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Novartis AG; Bristol Myers Squibb Company; GlaxoSmithKline PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. TCR Therapy Market Characteristics

3. TCR Therapy Market Trends And Strategies

4. TCR Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global TCR Therapy Market Size and Growth

  • 5.1. Global TCR Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global TCR Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global TCR Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. TCR Therapy Market Segmentation

  • 6.1. Global TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infusions
  • Injectables
  • Other Product Types
  • 6.2. Global TCR Therapy Market, Segmentation By Indication , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Leukemia
  • Lymphoma
  • Myeloma
  • Other Indications
  • 6.3. Global TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Online
  • Offline
  • 6.4. Global TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Specialty Clinics

7. TCR Therapy Market Regional And Country Analysis

  • 7.1. Global TCR Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global TCR Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific TCR Therapy Market

  • 8.1. Asia-Pacific TCR Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China TCR Therapy Market

  • 9.1. China TCR Therapy Market Overview
  • 9.2. China TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India TCR Therapy Market

  • 10.1. India TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan TCR Therapy Market

  • 11.1. Japan TCR Therapy Market Overview
  • 11.2. Japan TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia TCR Therapy Market

  • 12.1. Australia TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia TCR Therapy Market

  • 13.1. Indonesia TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea TCR Therapy Market

  • 14.1. South Korea TCR Therapy Market Overview
  • 14.2. South Korea TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe TCR Therapy Market

  • 15.1. Western Europe TCR Therapy Market Overview
  • 15.2. Western Europe TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK TCR Therapy Market

  • 16.1. UK TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany TCR Therapy Market

  • 17.1. Germany TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France TCR Therapy Market

  • 18.1. France TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy TCR Therapy Market

  • 19.1. Italy TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain TCR Therapy Market

  • 20.1. Spain TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe TCR Therapy Market

  • 21.1. Eastern Europe TCR Therapy Market Overview
  • 21.2. Eastern Europe TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia TCR Therapy Market

  • 22.1. Russia TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America TCR Therapy Market

  • 23.1. North America TCR Therapy Market Overview
  • 23.2. North America TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA TCR Therapy Market

  • 24.1. USA TCR Therapy Market Overview
  • 24.2. USA TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada TCR Therapy Market

  • 25.1. Canada TCR Therapy Market Overview
  • 25.2. Canada TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America TCR Therapy Market

  • 26.1. South America TCR Therapy Market Overview
  • 26.2. South America TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil TCR Therapy Market

  • 27.1. Brazil TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East TCR Therapy Market

  • 28.1. Middle East TCR Therapy Market Overview
  • 28.2. Middle East TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa TCR Therapy Market

  • 29.1. Africa TCR Therapy Market Overview
  • 29.2. Africa TCR Therapy Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa TCR Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa TCR Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. TCR Therapy Market Competitive Landscape And Company Profiles

  • 30.1. TCR Therapy Market Competitive Landscape
  • 30.2. TCR Therapy Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Novartis AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bristol Myers Squibb Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GlaxoSmithKline PLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. TCR Therapy Market Other Major And Innovative Companies

  • 31.1. Gilead Sciences Inc.
  • 31.2. Bluebird bio Inc.
  • 31.3. Immunocore Limited
  • 31.4. Immatics N.V.
  • 31.5. Poseida Therapeutics Inc.
  • 31.6. Fate Therapeutics Inc.
  • 31.7. Atara Biotherapeutics Inc.
  • 31.8. Intellia Therapeutics Inc.
  • 31.9. Precision Biosciences Inc.
  • 31.10. Takara Bio Inc.
  • 31.11. Tessa Therapeutics
  • 31.12. Adaptimmune Therapeutics plc
  • 31.13. Cellectis S.A.
  • 31.14. Zelluna Immunotherapy AS
  • 31.15. Cellular Biomedicine Group Inc.

32. Global TCR Therapy Market Competitive Benchmarking

33. Global TCR Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The TCR Therapy Market

35. TCR Therapy Market Future Outlook and Potential Analysis

  • 35.1 TCR Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 TCR Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 TCR Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer